Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Mesenchymal Stem Cell Conditioned Medium for Autonomic Nervous System-Related Disorders
jRCT1051230175Recruiting
- Sponsor
- Nagamine Medical Clinic Ginza
- Start
- Jan 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in dysautonomia, sponsored by Nagamine Medical Clinic Ginza. Primary endpoint: Assessment of self-reported symptoms of autonomic dysfunction. Started Jan 2024; status: recruiting.
02
Conditions
dysautonomia
Beyond the preview
Go deeper on jRCT1051230175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051230175.